Related Experiment Video
Updated: May 31, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver
Atsushi Takahashi1, Ryouhei Tsutsumi, Ippei Kikuchi
1Division of Microbiology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
Abstract:
Deregulation of SHP2 is associated with malignant diseases as well as developmental disorders. Although SHP2 is required for full activation of RAS signaling, other potential roles in cell physiology have not been elucidated. Here we show that SHP2 dephosphorylates parafibromin/Cdc73, a core component of the RNA polymerase II-associated factor (PAF) complex. Parafibromin is known to act as a tumor suppressor that inhibits cyclin D1 and c-myc by recruiting SUV39H1 histone methyltransferase. However, parafibromin can also act in the opposing direction by binding β-catenin, thereby activating promitogenic/oncogenic Wnt signaling. We found that, on tyrosine dephosphorylation by SHP2, parafibromin acquires the ability to stably bind β-catenin. The parafibromin/β-catenin interaction overrides parafibromin/SUV39H1-mediated transrepression and induces expression of Wnt target genes, including cyclin D1 and c-myc. Hence, SHP2 governs the opposing functions of parafibromin, deregulation of which may cause the development of tumors or developmental malformations.
Insights
SHP2 dephosphorylation of parafibromin (Cdc73) activates Wnt signaling by promoting β-catenin binding. This mechanism links SHP2 to both cancer and developmental disorders by controlling parafibromin
Area of Science:
- Molecular Biology
- Cellular Signaling
- Oncology
Background:
- SHP2 (PTPN11) is implicated in malignant diseases and developmental disorders.
- SHP2's role in RAS signaling is established, but other cellular functions are unclear.
- Parafibromin (Cdc73) is a tumor suppressor that inhibits cyclin D1 and c-myc via SUV39H1.
Purpose of the Study:
- To elucidate the role of SHP2 in regulating parafibromin's function.
- To investigate how SHP2 influences parafibromin's interaction with other proteins.
- To understand the implications of SHP2-mediated parafibromin regulation in disease.
Main Methods:
- Biochemical assays to detect SHP2-mediated dephosphorylation of parafibromin.
- Co-immunoprecipitation to assess parafibromin binding to β-catenin and SUV39H1.
- Analysis of Wnt target gene expression, including cyclin D1 and c-myc.
Main Results:
- SHP2 dephosphorylates parafibromin on tyrosine residues.
- Dephosphorylated parafibromin stably binds to β-catenin, overriding SUV39H1 recruitment.
- SHP2-induced parafibromin/β-catenin interaction activates Wnt signaling and upregulates oncogenic genes.
Conclusions:
- SHP2 governs the dual functions of parafibromin, switching it from tumor suppression to oncogenesis.
- Dysregulation of this SHP2-parafibromin axis contributes to tumor development and congenital abnormalities.
- Targeting SHP2 may offer therapeutic strategies for diseases linked to aberrant parafibromin activity.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

